Australia markets close in 4 hours 58 minutes

Lumos Pharma, Inc. (LUMO)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
2.6200+0.1600 (+6.50%)
At close: 04:00PM EDT
2.6200 -0.14 (-5.07%)
After hours: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,051
2,051
1,523
230
168
Operating expenses
Research development
22,096
22,096
17,857
16,246
9,206
Selling general and administrative
16,569
16,569
15,706
15,331
17,265
Total operating expenses
38,665
38,665
33,563
31,577
26,471
Operating income or loss
-36,614
-36,614
-32,040
-31,347
-26,303
Interest expense
98
-
-
-
-
Total other income/expenses net
683
683
91
269
6,467
Income before tax
-34,063
-34,063
-31,075
-31,066
-19,636
Income tax expense
-29
-29
-13
-636
-13,973
Income from continuing operations
-34,034
-34,034
-31,062
-30,430
-5,663
Net income
-34,034
-34,034
-31,062
-30,430
-5,663
Net income available to common shareholders
-34,034
-34,034
-31,062
-30,430
-6,314
Basic EPS
-3.99
-4.18
-3.71
-3.65
-0.93
Diluted EPS
-3.99
-4.18
-3.71
-3.65
-0.93
Basic average shares
8,217
8,145
8,374
8,335
6,778
Diluted average shares
8,217
8,145
8,374
8,335
6,778